Home Finance Pfizer-BioNTech Booster 95.6% Effective in Trial, Companies Say

Pfizer-BioNTech Booster 95.6% Effective in Trial, Companies Say

46
0

Pfizer-BioNTech Booster 95.6% Effective in Trial, Companies Say


A third dose of the Pfizer-BioNTech Covid-19 vaccine has been authorized for adults 65 years and older and others at high risk.

Photo: Bob Daemmrich/Zuma Press

Published at Thu, 21 Oct 2021 13:38:00 +0000

https://www.wsj.com/articles/pfizer-biontech-covid-19-booster-shot-was-95-6-effective-in-large-trial-companies-say-11634823482?mod=pls_whats_news_us_business_f

Previous articleHouse Votes to Hold Steve Bannon in Contempt for Defying January 6 Committee Subpoena
Next articleThis Sweater Dress From Amazon Is the Coziest Winter Essential